PCI术后PAPP-A与再狭窄及瑞舒伐他汀的关系(1)
【摘要】最近(妊娠相关蛋白A)PAPP-A被列为冠心病患者血液的炎症血清学标志物之一,在PCI术后再狭窄过程中起了重要作用,瑞舒伐他汀是3 - 羟基- 3 - 甲基戊二酰辅A(HMG - COA)还原酶抑制剂,能显著降低胆固醇的水平,己广泛应用于冠心病的预防和治疗。大量药物临床实验,都证实不仅可以降低血脂水平,而且还具有抗炎,抑制血管平滑增殖等多效性作用,从而减少(经皮冠脉介入治疗)PCI术后再狭窄的发生。【关键词】pcI术papp-A瑞舒伐他汀
中图分类号:R563.8文献标识码:A文章编号:1005-0515(2010)11-301-03
pregnancy-associated plasma protein- A after percutaneous coronary intervention and restenosis and the relationship between rosuvastatin
【Abstract】PAPP-A(pregnancy-associated plasma-A) classified as one of the inflammation mark in serum has played an important role in restenosis post PCI in coronary heart disease patients. Rosuvastatin ......
您现在查看是摘要页,全文长 5050 字符。